SCHEMBL18486017

SCHEMBL18486017

CC1=C(CCOc2nccnc2-c2ccc(N)cc2)SCN1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 5/20 0.35
▸ SQOR Q9Y6N5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18483481 0.83 IDO1 (0.35) PDE10A
SCHEMBL18448789 0.73 CYP4F2 (0.49) PDE10A
SCHEMBL18448289 0.71 NPC1 (0.55) PDE10A
SCHEMBL18447768 0.70 LMNA (0.36) PDE10A
SCHEMBL18448780 0.67 PDE10A (0.35) PDE10A
SCHEMBL22271059 0.63 KDM4A (0.37) SQOR
SCHEMBL18447639 0.63 MAOB (0.53) —
SCHEMBL18448243 0.63 EP300 (0.44) —
SCHEMBL10726634 0.62 ALDH1A1 (0.53) PDE10A
SCHEMBL18448284 0.62 LMNA (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017021879-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-02-09 — — WO disclosed
Send feedback